Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study

Affiliations

• ¹ AARA Research Center, 10100 N. Central Expressway, Suite 100, Dallas, TX, 75231, USA. Lumrymd@AARAResearch.com.
• ² Department of Medicine, UC San Diego, La Jolla, CA, USA.
• ³ University of Milan, Milan, Italy.
• ⁴ Penn State University College of Medicine, Hershey, PA, USA.
• ⁵ Clinical Research Center of Alabama, Birmingham, AL, USA.
• ⁶ Massachusetts General Hospital, Boston, MA, USA.
• ⁷ University of Cincinnati College of Medicine and Bernstein Clinical Research Center, LLC, Cincinnati, OH, USA.
• ⁸ Allergy Department, Hospital La Paz Institute for Health Research (IdiPaz), Biomedical Research Network On Rare Diseases (CIBERER U754), Madrid, Spain.
• ⁹ Hungarian Angioedema Reference Center, 3Rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
• ¹⁰ Maryclif Clinical Research, Spokane, WA, USA.
• ¹¹ McMaster University, Hamilton, ON, USA.
• ¹² UC Irvine, Orange, CA, USA.
• ¹³ Institute for Asthma and Allergy, Chevy Chase, MD, USA.
• ¹⁴ Department of Dermatology and Allergy, Charité, Universitätsmedizin Berlin, Berlin, Germany.
• ¹⁵ Medical Research of Arizona, Scottsdale, AZ, USA.
• ¹⁶ Division of Rheumatology, Allergy and Immunology, University of California, San Diego, La Jolla, CA, USA.
• ¹⁷ CSL Behring GmbH, Emil-von-Behring-Strasse 76, Marburg, Germany.
• ¹⁸ University College Hospital, London, UK.
• ¹⁹ Auckland District Health Board, Auckland, New Zealand.